Virios Therapeutics (VIRI) Tops Q3 EPS by 3c

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Roblox announces standalone apps, browser play, and creator wallet
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day